|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.95 USD | -0.25% |
|
+2.66% | +0.97% |
| 09/12 | Umb Financial Insider Sold Shares Worth $1,760,751, According to a Recent SEC Filing | MT |
| 02/12 | Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bullish |
| Resistance | 115.88 | 125.59 | 124.47 |
| Spread/Res. | -1.67% | -9.27% | -8.45% |
| Spread/Supp. | +3.37% | +15.43% | +8.74% |
| Support | 110.23 | 98.72 | 104.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- UMBF Stock
- Charts UMB Financial Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition